Analysis of KIR ligand incompatibility in human renal transplantation

Transplantation

Volumn 80, Issue 8, 2005, Pages 1121-1123

  Tran, T Hien ^a   Mytilineos, Joannis ^a   Scherer, Sabine ^a   Laux, Gunter ^a   Middleton, Derek ^b   Opelz, Gerhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Graft survival; Killer immunoglobulin like receptors; Major histocompatibility complex; Natural killer cells; Renal transplantation

Indexed keywords

EPITOPE; HLA B ANTIGEN; HLA BW4 ANTIGEN; HLA C ANTIGEN; HLA CW ANTIGEN; IMMUNOGLOBULIN RECEPTOR; KILLER IMMUNOGLOBULIN LIKE RECEPTOR; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG;

ALLELE; ANTIGEN BINDING; ARTICLE; CADAVER DONOR; CELL KILLING; GRAFT SURVIVAL; HUMAN; KAPLAN MEIER METHOD; KIDNEY ALLOGRAFT; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; PRIORITY JOURNAL; RECIPIENT; TARGET CELL;

GRAFT SURVIVAL; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; KILLER CELLS, NATURAL; LIGANDS; RECEPTORS, IMMUNOLOGIC;

EID: 27744509825     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000179110.15304.90     Document Type: Article

References (15)

1. French AR, Yokoyama WM. Natural killer cells and viral infections. Current Opinion Immunol 2003; 15: 45.
2. Wu J, Lanier LL. Natural killer cells and cancer. Adv Cancer Res 2003; 90: 127.
3. Cella M, Longo A, Ferrara GB, et al. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 1994; 180: 1235.
4. Colonna M, Borsellino G, Falco M, et al. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci USA 1993; 90: 12000.
5. Colonna M, Brooks EG, Falco M, et al. Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science 1993; 260: 1121.
6. Ljunggren HG, Karre K. In search of the 'missing self'. MHC molecules and NK cell recognition. Immunol Today 1990; 11: 237.
7. Parham P, McQueen K. Alloreactive killer cells:hindrance and help for hematopoietic transplants. Nature Rev Immunol 2003; 3: 108.
8. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097.
9. Mytilineos J, Christ U, Lempert M, et al. Comparison of typing results by serology and polymerase chain reaction with the sequence-specific primers for HLA-Cw in 650 individuals. Tissue Antigens 1997; 50: 395.
10. Davies SM, Ruggieri L, DeFor T, et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Blood 2002; 100: 3825.
11. Giebel S, Locatelli F, Lamparelli T, et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 2003; 102: 814.
12. Kaplan EL, Meier P. Nonparametric estimation form incomplete observations. J Am Stat Assoc 1958; 53: 457.
13. Cox DR. Regression models and life-tables. J R Stat Soc 1972; 34: 187.
14. Klein JP, Moeschberger ML. Survival analysis-techniques for censored and truncated data. New York: Springer, 1997: 233.
15. Trowsdale J, Barten R, Haude A, et al. The genomic context of natural killer receptor gene families. Immunol Rev 2001; 181: 20.